NEW YORK (GenomeWeb News) — Bioinformatics shop CLC Bio has received an undisclosed amount of new financial backing from several new private Danish investors, the company said today.
 
The new backers include Peter Bogild, Tom Nordin, and Thomas Bruno, who have a combined capital base of $200 million, the company said.
 
CLC Bio will use the funding to continue developing software for next-generation sequencing and to continue to enhance its current product line, company CEO Thomas Knudsen said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.